Podcasts about Lipoprotein

Join Dr. Kahn for the 4th Reversing Heart Disease Summit beginning March 7, 2026. The event is free to attend online. Register here: drtalks.com/summits/reversing-heart-disease This week, Dr. Kahn reviews new research examining the connection between red meat consumption and the risk of diabetes, elevated cholesterol, and cancer. He also discusses findings from a large study showing that vegetarian diets are associated with a lower risk of several types of cancer.  Additional topics include emerging treatments for Lipoprotein(a), the role of coronary CT angiography in women and in individuals with a family history of heart disease, newly identified predictors of cardiovascular risk in women, dietary patterns that support brain health, and screening strategies to reduce the risk of cardiac arrest in young athletes.  Thanks to Igennus. Visit igennus.com and use the discount code DrKahn for savings on their products.

This week, Dr. Kahn discusses his current health challenge: a leaky mitral valve due to mitral valve prolapse, a condition of unknown cause that is unrelated to lifestyle or diet. He reviews data on mitral valve surgery, comparing repair to replacement, as well as the current availability of robotic surgery and its advantages. He plans to keep the Heart Doc VIP community updated on his status and is feeling great day to day. Short topics this week include wine, olive oil, plant-based diets for breast cancer, Life's Essential 8, the health of babies raised in vegan families, and new data on Lipoprotein(a).  Thanks to Igennus. Use the discount code DRKAHN at igennus.com .

Leslie J Donato. A Turning Point for Lipoprotein(a) Treatment: Are Clinical Laboratories Ready? Clinical Chemistry, Volume 72, Issue 2, February 2026, Pages 222–224. https://doi.org/10.1093/clinchem/hvaf101

When doctors said, “There's nothing more we can do,” LeAnn Wheeler refused to accept that as the final verdict.After multiple procedures, a failed bypass, and being labeled a “no-option” cardiac patient, LeAnn discovered Enhanced External Counterpulsation (EECP) — a non-invasive, FDA-approved, Medicare-covered therapy that has existed for decades but remains largely unknown in the United States.In this powerful conversation, we discuss:• What it feels like to be told you're out of options• The science behind angiogenesis and how the body can grow new blood vessels• Lipoprotein(a) and the hidden genetic risk most patients are never tested for• Why EECP is widely used internationally but underutilized in America• What patients need to know if they're searching for real answersLeAnn now works to bring awareness and access to EECP through Thrive ECP, helping others avoid the devastating moment she experienced.Learn more:https://thriveecp.comThis episode is for anyone navigating heart disease, advocating for a loved one, or questioning whether “no more options” is really the end of the story.

Cholesterin wurde lange Zeit auf gutes HDL- und schlechtes LDL-Cholesterin reduziert – dass diese Sicht zu kurz greift, belegt aktuelle Forschung. In dieser Episode spricht Priv.-Doz. Dr. med. habil. Katharina Lechner vom Helmholtz Zentrum München über einen Marker, der das kardiovaskuläre Risiko präziser abbilden kann als LDL-Cholesterin allein: Apolipoprotein B (ApoB). Wir besprechen, - warum eine Messung der Anzahl aller ApoB-Partikel das individuelle Herz-Kreislauf-Risiko genauer widerspiegelt als klassische Cholesterinwerte. - wieso genetisch bedingte Fettstoffwechselstörungen durch einen gesunden Lebensstil nicht ausreichend kontrollierbar sind. - wann eine medikamentöse Therapie sinnvoll ist – und welche modernen Behandlungsmöglichkeiten zur Verfügung stehen. - warum Lipoprotein(a) als eigenständiger Risikofaktor mindestens einmal im Leben gemessen werden sollte. - welche Rolle die Ernährung, regelmäßiges Krafttraining und Schlaf in der Prävention spielen. Katharina Lechner erklärt, wie moderne Medizin Risiken frühzeitig sichtbar machen kann, lange bevor Symptome auftreten. Die renommierte Kardiologin und Forscherin mit Schwerpunkt auf Lipidologie und personalisierter Prävention zeigt, wie patientenzentrierte, datenbasierte und lebensbegleitende Strategien unsere Gefäßgesundheit langfristig schützen können."Der ERCM Medizin Podcast" Social & Webseite:Instagram: https://www.instagram.com/ercm.podcast/ TikTok: https://www.tiktok.com/@ercm.podcast?lang=de-DE Webseite: http://www.erc-munich.com Kontakt: podcast@erc-munich.comPrivatdozentin Dr. med. Katharina Lechner:Helmholtz Zentrum München: https://www.helmholtz-munich.de ("https://www.helmholtz-munich.de")Über das ERCM:Im Europäischen Radiochirurgie Centrum München (ERCM) setzen wir seit über 20 Jahren auf präzise Tumortherapien: hochmoderne Radiochirurgie und innovative Medizintechnologien zur gezielten und schonenden Behandlung verschiedener Tumoren – gutartige Neubildungen ebenso wie schwere Krebserkrankungen. Jahr für Jahr schenken uns mehr als 1.000 Patientinnen und Patienten ihr Vertrauen auf dem Weg zu einer individuell abgestimmten Therapie. Unser Ziel: Personalisierte, präzise und vor allem patientenzentrierte Behandlungen, die auf eine effektive und nebenwirkungsarme Therapie bei guter Lebensqualität fokussieren.(00:00:00) Intro(00:00:50) ApoB: Der wichtigste Marker für Herz-Kreislauf-Risiko(00:07:24) Warum ApoB nicht im Standard-Labor ist(00:09:50) Normalwerte vs. Idealwerte: Der größte Blindspot(00:18:04) Deutschland im europäischen Vergleich: Letzter Platz(00:19:23) Genetische vs. erworbene Fettstoffwechselstörungen(00:54:48) Lipoprotein(a): Der vergessene Risikofaktor(00:32:25) Cardio-CT: Plaques sichtbar machen(00:42:07) Statine: Wirkung, Nebenwirkungen und richtige Dosierung(00:46:00) Neue Therapien: Von Antikörpern bis CRISPR(01:11:22) Ketogene Ernährung: Lean Mass Hyper-Responder(01:01:21) Lebensstil: Die 95-Prozent-Regel für Gesundheit(01:09:01) CORA Digital Fit: Personalisiertes Coaching(01:21:14) Take-Home-Message: Die drei wichtigsten Werte#Cholesterin #ApoB #LipoproteinA #Herzinfarkt #Schlaganfall #Prävention #Statine #Lipidstoffwechsel #CardiovaskuläreGesundheit #Fettstoffwechsel #HerzKreislauf #ERCMPodcast #KatharinaLechner #PCSK9 #Kardiologie

In dieser Folge spreche ich mit Prof. Martin Halle, einem der profiliertesten Experten für Präventionsmedizin und Sportkardiologie in Deutschland. Ausgangspunkt unseres Gesprächs sind alarmierende Daten: Deutschland liegt im europäischen Vergleich bei der Gesundheitsvorsorge auf einem der hinteren Plätze. Professor Halle erklärt, warum Prävention hierzulande strukturell vernachlässigt wird – und was sich ändern muss. Wir sprechen über personalisierte Präventionschecks, über Blutdruck, Herz-Kreislauf-Risiken, moderne Diagnostik und den sinnvollen Einsatz von Wearables. Es geht um die Frage, wie wir nicht nur länger, sondern gesünder leben können – und warum Prävention ein langfristiges Investment in unsere Lebensqualität ist. In dieser Folge sprechen wir u.a. über folgende Themen:  Warum schneidet Deutschland bei der Prävention im europäischen Vergleich so schlecht ab? Warum ist Prävention ein langfristiges Investment in Lebensqualität und Gesundheit? Weshalb stehen Herz-Kreislauf-Erkrankungen im Zentrum moderner Präventionsstrategien? Welche diagnostischen Schritte sind für eine personalisierte Prävention entscheidend? Welche Blutmarker liefern frühe Hinweise auf Alterungs- und Krankheitsprozesse? Warum ist Lipoprotein(a) ein unterschätzter, aber relevanter Risikofaktor? Welche Rolle spielen Wearables bei der individuellen Gesundheitsbewertung? Warum sind optimale Blutdruckwerte wichtiger als das bloße Einhalten von Grenzwerten? Welche langfristigen Folgen hat unerkannter oder unzureichend behandelter Bluthochdruck? Wie lassen sich Lebensstilmaßnahmen und medikamentöse Therapien sinnvoll kombinieren? Warum muss Prävention bereits im Kindes- und Jugendalter beginnen? Wie können personalisierte Präventionsprogramme nachhaltige Verhaltensänderungen bewirken? Weitere Informationen zu Prof. Martin Halle findest du hier: https://www.sport.mri.tum.de/de/ueber-uns/team/leitung/univ-prof-dr-med-martin-halle Du interessierst dich für Gesunde Langlebigkeit (Longevity) und möchtest ein Leben lang gesund und fit bleiben, dann folge mir auch auf den sozialen Kanälen bei Instagram, TikTok, Facebook oder YouTube. https://www.instagram.com/nina.ruge.official https://www.tiktok.com/@nina.ruge.official https://www.facebook.com/NinaRugeOffiziell https://www.youtube.com/channel/UCOe2d1hLARB60z2hg039l9g   Disclaimer: Ich bin keine Ärztin und meine Inhalte ersetzen keine medizinische Beratung. Bei gesundheitlichen Fragen wende dich bitte an deinen Arzt/deine Ärztin.  STY-254 

This week, Dr. Kahn breaks down a new paper examining the risks and reported side effects of statins—including the surprising finding that placebo alone is linked to many of the same symptoms. He also covers an oral PCSK9 inhibitor currently under study and what it could mean for cholesterol management. The episode then dives into the latest research on emerging therapies designed to lower lipoprotein(a), including a real-world case study that highlights where this rapidly evolving field is headed.  Shorter discussions include heart disease at a young age, why so many patients fail to reach blood pressure treatment goals, aspirin use one year after AFib ablation, skeletal muscle as an endothelial stabilizer, and why exercise variety may be one of the most powerful risk reducers we have.  Thanks to WellBean for sponsoring the show. Save on their delicious bean-based products at wellbean.life with code DrKahn15.  Dr. Kahn will also be leading a free online seminar on cholesterol on February 17, 2026 at 7 PM EST with Forks Over Knives. Register HERE.

Send us a textDr. H. Jackson Downey sits down with MedEvidence!™ to give the low-down on keeping your lipoprotein(a) numbers down. Lipoprotein little a, also called Lp(a), is a really, really, really, really, really bad cholesterol that is genetically determined, meaning exercise and diet don't help lower the numbers. Instead, Dr. Downey explains, clinical trials are looking into investigational medications for this bad type of cholesterol. Dr. Downey describes the ins and outs of Lp(a) and how clinical research is our best bet for solutions to this dangerous cholesterol.Be a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on Apple PodcastsWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramX (Formerly Twitter)LinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Weight frustration in perimenopause isn't just about vanity—it's about a physiological shift that changes how our bodies handle fuel. In this episode, Dr. Rachel Pope sits down with midlife health expert Ann Konkoly to demystify GLP-1 medications (like Ozempic and Zepbound), the hidden dangers of visceral fat, and why the scale is often a "shitty measurement" for your actual health.In this episode, we discuss: The "Middle" Mystery: Why the "eat less, move more" mantra fails women in perimenopause and how this transition impacts weight maintenance. GLP-1s Beyond Weight Loss: Ann explains the metabolic benefits of these medications, including reducing neuroinflammation and protecting the heart and kidneys. The Hidden Danger of Visceral Fat: Why a "normal BMI" can be misleading and how internal fat affects your risk for chronic disease. Synergy with MHT: How optimizing cardiovascular health can create a safer "on-ramp" for starting hormone replacement therapy. Preserving Lean Muscle: Strategies for "muscle-centric medicine" to ensure weight loss doesn't come at the expense of your strength and bone density. The HOMA-IR Hack: A simple way to use fasting glucose and insulin levels to see if insulin resistance is your primary roadblock. Planning for your later years: Why the choices you make in your 40s and 50s determine your mobility and independence in your 80s and 90s.The "Proactive Midlife" Lab ChecklistAnn suggests asking your provider for these specific markers to get a true picture of your metabolic health: Fasting Insulin & Fasting Glucose (to calculate your HOMA-IR score). Lipid Panel (focusing on Triglycerides). Lipoprotein(a) & hs-CRP (markers of inflammation and genetic heart risk). Body Composition Analysis (to track muscle mass vs. visceral fat).About Ann:Ann Konkoly is a board-certified Nurse Practitioner, Certified Nurse Midwife, and Menopause Society Certified Practitioner. She is the founder and CEO of Kultivate Women's Health in Beachwood, Ohio, where she specializes in evidence-based hormone therapy, metabolic health, and medical weight management.Connect with Ann: Website: www.kultivatewomenshealth.com/about Instagram: www.instagram.com/annkonkoly.npConnect with Dr. Rachel Pope: Website: ourwomanity.comSocial Media: @drrachelpope

Broadcast from KSQD, Santa Cruz on 1-22-2026: An emailer from Canada asks about long-term Remicade (infliximab) use for her 16-year-old daughter's ulcerative colitis. Dr. Dawn explains the drug blocks tumor necrosis factor, which stops autoimmune attacks but also weakens infection defense—increasing risk of fungal infections, tuberculosis, and after about 10 years, slightly elevated blood cancer risk. She recommends the daughter practice good hygiene and mask in high-risk settings. For achieving full remission, she suggests vitamin D levels around 75-80, DHEA supplementation, strict gluten avoidance due to its pro-inflammatory effects, and working with a certified functional medicine practitioner to heal the gut and potentially withdraw medication. Dr. Dawn presents a case study of a 27-year-old woman with progressive weakness, pins-and-needles sensations, and impaired balance. Despite normal B12 blood levels, elevated homocysteine and methylmalonic acid revealed functional B12 deficiency from using 20-30 nitrous oxide whippets daily. Nitrous oxide oxidizes the cobalt atom in methylcobalamin, permanently inactivating the enzyme needed for myelin sheath maintenance. Treatment requires months of daily B12 injections with recovery taking up to 84 weeks. She warns that nitrous oxide also interacts dangerously with Viagra-type drugs (causing dangerous blood pressure drops), methotrexate, stimulants, hallucinogens, and respiratory depressants. She describes Canadian researchers developing a miniaturized 3D printer for vocal cord repair. After removing nodules that cause hoarseness, the device prints hydrogel along the wound to create a flat surface preventing keloid-like regrowth, rather like spackling a wall before healing occurs underneath. Dr. Dawn discusses lipoprotein(a), written as Lap(a), a genetic cardiovascular risk factor discovered in the 1960s. This relative of LDL carries a protein that promotes blood clots, thus raising heart attack and stroke risks. In a recent large survey, only about 14% of people have been screened despite its significance. New drugs like pelicarsin can reduce Lp(a) levels up to 80%,trials underway to confirm a benefit of reduced cardiac events. She notes tennis star Arthur Ashe had high Lp(a) contributing to his coagulopathy. A natural option is already available. She recommends lumbrokinase, derived from earthworms and used in traditional Chinese medicine, as an existing treatment that combats high Lp(a) and counteracts its procoagulant effects. The product Boluoke is commercially available, offering an alternative to high-dose niacin which causes intolerable flushing and diarrhea. Dr. Dawn reports research finding people with anxiety disorders have 8% lower choline levels in brain regions regulating emotion. Increasing choline could help. Choline sources include eggs (two eggs provide 300mg of the 500mg daily choline need), organ meats, salmon, soybeans, and lecithin supplements.

I was shocked at the comments on this post. Many people, some of them I know to be smart, thought I was nuts for suggesting two middle-aged women who had isolated high LDL-C needn't take meds because their calculated 10-year risk was less than 3% What shocked me is that our guidelines suggest treatment with statins when 10-year risk is ≥ 7.5%. You may not know this but clinicians are supposed to consider cholesterol (and BP) based on overall risk, which include things like age, blood pressure, smoking status as well as HDL. Here is a link to the PCE. It drives me bananas that clinicians don't go over this with patients. They just look at LDL-c in isolation. Content like this comes free of industry support. Please consider becoming a free or paid subscriber.Experts chose this a 7.5% threshold because they felt it was the point where the absolute risk reduction from statins (about 20-25% relative risk reduction) for nonfatal cardiac events outweighed any potential downsides of statins. It is an arbitrary threshold. The thinking: We know from many RCTs that statins reduce future risk by about 20-25% over 5 years. So .25 x the estimated risk outputs the absolute risk reduction. Let's say a person has a calculated risk of 10%. They can expect a 2.5% risk reduction (.25 x 10% = 2.5%) over 10 years. But .25 x 3% = .75, so a person with an estimated risk of 3% who takes a daily pill for 10 years goes to 2.25%. That's not much. Here are some pics of the pushback I recieved:My colleagues rightly point out that atherosclerosis of the coronary arteries is a slow process and longer exposure to lower LDL-c is beneficial. They feel that the 10-year horizon is too short. They cite something called Mendelian randomization studies which find that people who were born with genetic profiles that cause low cholesterol also have low rates of heart attacks. I wrote a post about this. I actually think that statins and blood pressure drugs may have greater effects in younger people who are at lower risk. But come on. Both individuals who I helped calculate risk were below 3%. That's too low to worry about. Further, if you think we treat people with elevated LDL levels who have this low of a risk, why do we need risk calculators? Or…why don't we just treat everyone above a certain age, since age is the largest driver in the calculators? These are issues I spoke with Drs Foy and Murthy about. I learned a ton. I hope you will too. Topics include:* The value of risk calculators* The uncertainty of prediction* The best time window to consider (statin trials were for 5 years; can we assume effect sizes over 5 years are similar at 30 years?) * The causal role of LDL-c vs “metabolic health”* The value of coronary artery calcium testing * Lipoprotein (a) Academic people like to make fun of podcasts, but I can't imagine a more educational 40 minutes. Andrew and Venk are two of the most thoughtful people in cardiology today. Enjoy and consider supporting Sensible Medicine This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.sensible-med.com/subscribe

In dieser Episode spricht Dr. Helmut Brath mit Dr. Florian Kronenberg über die klinische Bedeutung von Lipoprotein(a).Erfahren Sie, bei welchen Patient:innen eine Bestimmung von Lp(a) sinnvoll ist, wie erhöhte Werte interpretiert werden und welche therapeutischen Strategien aktuell zur Verfügung stehen — von Risikostratifizierung bis zur individualisierten Behandlung.Dieser Beitrag entstand im Rahmen der medconnect.at-Fortbildung„siRNA und Co: Neue Wege in der Lipidtherapie“,unter der wissenschaftlichen Leitung und Moderation von Dr. Helmut Brath.

Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I'm a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients. In this episode, Dr Warrick Bishop explains the real role of cholesterol in the body and why simple labels like “good” and “bad” cholesterol don't tell the whole story. He breaks down LDL, HDL, triglycerides, and Lipoprotein(a), highlighting how each contributes to understanding cardiovascular risk.

This week on Heart Doc VIP, Dr. Joel Kahn takes a fresh look at niacin (vitamin B3) therapy and its role in managing cholesterol and Lipoprotein(a). He reviews both classic and recent research, explains why many clinicians have moved away from niacin, and then walks through data that suggest it may still have value when used thoughtfully and selectively. Dr. Kahn also shares a real-world case study highlighting how niacin can be effective when carefully monitored. In the episode's shorter segments, Dr. Kahn covers a wide range of timely topics, including the relationship between orange juice and heart disease, the link between uterine fibroids and cardiovascular risk, and why achieving remission from pre-diabetes matters more than ever. He also explores research on polyphenol-rich Tartary buckwheat and its potential connection to slower aging, as well as new findings on statin use and muscle strength.  As always, the episode blends evidence-based medicine with practical insights you can apply to your own heart-health journey.  Sponsor:  Thanks to koyah.com/KAHN10 — check out their excellent product line and save with the code KAHN10.

Commentary by Dr.  Jian'an Wang.

Send us a message with this link, we would love to hear from you. Standard message rates may apply. In this episode of Your Checkup, we break down lipoprotein(a) — a largely inherited form of cholesterol that can significantly increase the risk of heart disease and stroke, even when standard cholesterol numbers look normal. We talk about what Lp(a) is, why it matters, who should be tested, and how it helps explain “unexpected” heart events in otherwise healthy people. While Lp(a) can't currently be lowered with diet or exercise, knowing your level allows you and your care team to be more intentional about prevention by aggressively managing other risk factors like LDL cholesterol, blood pressure, and diabetes. We also discuss what the numbers mean, why most people only need to be tested once, and the promising treatments currently being studied that may change care in the future. References (for Show Notes)Nordestgaard BG, Langsted A. Lipoprotein(a) and Cardiovascular Disease. Lancet. 2024;404(10459):1255-1264.Reyes-Soffer G, et al. AHA Scientific Statement on Lipoprotein(a). Arterioscler Thromb Vasc Biol. 2022;42(1):e48-e60.Di Fusco SA, et al. Lipoprotein(a): Risk Factor and Emerging Target. Heart. 2022;109(1):18-25.Nasrallah N, et al. Lp(a) in Clinical Practice. Eur J Clin Invest. 2025:e70127.Greco A, et al. Lipoprotein(a) as a Pharmacological Target. Circulation. 2025;151(6):400-415.Bess C, Mehta A, Joshi PH. All We Need to Know About Lipoprotein(a). Prog Cardiovasc Dis. 2024;84:27-33.Support the showSubscribe to Our Newsletter! Production and Content: Edward Delesky, MD & Nicole Aruffo, RNArtwork: Olivia Pawlowski

This week, Dr. Joel Kahn dives into a timely topic: how cold weather affects heart health. He breaks down why snow shoveling can put extra stress on the heart, what warning signs to watch for, and the simple steps anyone can take to stay safe — especially when the risks can include sudden cardiac events. He also covers a grab-bag of fascinating updates, including new insights on Lipoprotein(a) and blood type, how kimchi may support immune health, what plant-based diets mean for muscle, the link between beer bellies and heart disease, and a look at President Trump's recent heart check-up.  Special thanks to therasage.com — use code DRKAHN20 for discounts on products like the TheraPro Pad, one of Dr. Kahn's go-to wellness tools.

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on Lipoprotein(a) Testing Trends in the United States 2015-2024: An Analysis of 300 Million Individuals.

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on Elevated Lipoprotein(a) Independently Increases Risk for Short-Term Atherosclerotic Cardiovascular Events in Machine Learning Predictive Models.

Jeffrey W Meeusen, Xin Yi, Steven W Cotten, Jacob B Nielsen, Leslie J Donato, Patricia M Jones, Alagar R Muthukumar, Rafael Zubirán, Alan T Remaley, Jing Cao, Modern Low-Density Lipoprotein Cholesterol Formulas Outperform Direct Methods in Patients with Hypertriglyceridemia and Low Levels of Low-Density Lipoprotein Cholesterol, Clinical Chemistry, Volume 71, Issue 11, November 2025, Pages 1138–1146, https://doi.org/10.1093/clinchem/hvaf099

Dr. Erin Faules speaks with Dr. Damon Forbes about Lp(a), a genetically influenced lipoprotein linked to cardiovascular disease risk. They discuss how Lp(a) differs from LDL, its role in plaque and clotting, and why a one-time test can help clarify long-term risk. The conversation covers who to screen and when, interpreting Lp(a) alongside apoB and metabolic health, evidence-based ways to lower overall cardiovascular risk, and emerging Lp(a)-lowering therapies

“I think everyone should have Lp(a) measured.”  - Dr. Ann Marie Navar   Key Resources to Go Deeper:  - Dr. Ann Marie Navar  - Lp(a)  - Get a Free Test to Check Your Lp(a) Level   - Previous episode with Dr. Navar about ApoB  About This Episode:  Listen to this replay of an important discussion about Lipoprotein(a), or Lp(a), a critical but often overlooked marker for cardiovascular health. In this episode, host Barbara Hannah Grufferman takes a deep dive with medical expert Dr. Ann Marie Navar from UT Southwestern Medical Center about why this single test could be vital for understanding your heart disease risk, especially if you have a family history of early cardiovascular disease.  Key Topics Covered:  - What Lipoprotein(a) is and how it differs from standard cholesterol measurements  - Why Lp(a) testing is particularly important for certain individuals  - The genetic nature of Lp(a) and its implications for family health  - Current treatment options and promising new therapies on the horizon  - Practical steps for discussing Lp(a) testing with your healthcare provider  Key Takeaways:  - Lp(a) is a distinct type of cholesterol particle not captured in routine lipid panels  - High Lp(a) levels significantly increase risk of heart disease and stroke  - Lp(a) levels are primarily determined by genetics and remain stable throughout life  - Current guidelines recommend universal Lp(a) testing for adults  - New treatments specifically targeting high Lp(a) levels are expected by 2026  - Managing other risk factors can help offset the risk of elevated Lp(a)  - Coronary artery calcium scoring can provide additional risk assessment  Learn More About Dr. Ann Marie Navar  Dr. Navar is a preventive cardiologist and epidemiologist at UT Southwestern Medical Center whose research focuses on cardiovascular disease prevention, risk prediction, and clinical decision-making. She is a leading expert in advanced lipid testing and cardiovascular risk assessment. This is Dr. Navar's second appearance on AGE BETTER, following her previous discussion about the ApoB test, which was one of the most down-loaded episodes in 2024.   Connect With Barbara:  Have ideas for future episodes? We'd love to hear from you!  - Email: agebetterpodcast@gmail.com  - Connect on Instagram HERE  Note: This episode is for informational purposes only and does not constitute medical advice. Please consult with your healthcare provider about your specific situation. Learn more about your ad choices. Visit megaphone.fm/adchoices

I'm excited to share a new AMA episode with you today, dedicated to risk factors specific to women. In this AMA session, I dive into the lifestyle factors that influence lipids, exploring the latest research and discussing Lp(a) and ApoB. Rather than answering your individual questions, I have woven them into the overall outline to create a cohesive and informative conversation. IN THIS EPISODE, YOU WILL LEARN: How women's lifestyle choices directly affect their lipid profiles How knowing if you're a hyper absorber or hyper producer of cholesterol will change your treatment strategy What the Boston Heart Cholesterol Balance test will reveal about your body's ability to handle cholesterol The best treatments for hyper absorbers, and the best treatments for hyper producers How hard plaque differs from soft plaque, and why that matters for women's heart health How the new AI-assisted Clearly scan provides a more complete cardiovascular risk picture than a standard calcium score How chronic stress and elevated cortisol fuel insulin resistance and inflammation, and damage blood vessel linings The benefits of Mediterranean-style eating for improving lipid balance, vasomotor symptoms, and overall metabolic health The importance of managing trauma, stress, and emotional health in midlife How my “n=1” experiment with Zetia and micro-dosed GLP-1s significantly improved my ApoB and inflammation markers Connect with Cynthia Thurlow   Follow on X Instagram LinkedIn Check out Cynthia's website Submit your questions to support@cynthiathurlow.com Resources:  Dietary natural products as emerging lipoprotein(a)-lowering agents The Effects of Menopause Hormone Therapy on Lipid Profile in Postmenopausal Women: A Systematic Review and Meta-Analysis An Update on Lipoprotein(a): The Latest on Testing, Treatment, and Guideline Recommendations

On this episode of the WHOOP Podcast, Emily Capodilupo, WHOOP SVP of Research, Algorithms, and Data, sits down with Dr. Dan Henderson, Primary Care Physician and WHOOP Medical Advisory Board Member, to dive deep into the development and impact of WHOOP Advanced Labs.Emily and Dr. Henderson break down the WHOOP Advanced Labs blood testing panel and how it integrates into your WHOOP data and insights. WHOOP Advanced Labs gives you a more complete picture of your health and this episode dives deeper into the influences of biomarkers like lipoprotein(a), Vitamin D, insulin resistance, and more.Dr. Henderson shares his perspective as a primary care physician on why regular blood testing is important for everyone – not just those experiencing symptoms. Learn how your biomarkers can help optimize your energy, recovery, and longevity to aid symptoms like fatigue, brain fog, and weight fluctuations. (00:39) Meet Dr. Dan Henderson, WHOOP Medical Advisory Board Member(01:02) WHOOP Advanced Labs & The Opportunity in Healthcare(08:38) Why Is Bloodwork Important?: Understanding Your Biomarkers(11:31) Vitamin D: Health Benefits and The Prominence of Deficiency(15:13) Normalizing Fatigue and What It Actually Means For Your Health(21:18) Insulin Resistance: What You Need To Know(25:28) Interpreting Results & Finding Solutions to Symptoms(32:10) Setting New Standards: Why Regular Bloodwork Is Essential(36:50) What is Lipoprotein(a) & What Does It Measure?(39:16) Life Changing Aspects of WHOOP Advanced Labs(42:52) Reaching A Larger Number of Patients with Technological Advancements  (48:29) Key Takeaways For The Audience(50:05) Using WHOOP Labs to Advocate For Care(54:12) Top 5 Symptoms That Can Be Understood with WHOOP Advanced LabsFollow Dr. Dan Henderson:LinkedInSupport the showFollow WHOOP: Sign up for WHOOP Advanced Labs Trial WHOOP for Free www.whoop.com Instagram TikTok YouTube X Facebook LinkedIn Follow Will Ahmed: Instagram X LinkedIn Follow Kristen Holmes: Instagram LinkedIn Follow Emily Capodilupo: LinkedIn

Drs Harrington, Rodriguez, and Ridker discuss the changing field of cardiac prevention, where imaging fits in, and the new concept of standard modifiable risk factor-less patients. This podcast is intended for healthcare professionals only. To read a transcript or to comment, visit https://www.medscape.com/author/bob-harrington Life's Essential 8: Updating and Enhancing the American Heart Association's Construct of Cardiovascular Health: A Presidential Advisory From the American Heart Association https://doi.org/10.1161/CIR.0000000000001078 Development and Validation of the American Heart Association's PREVENT Equations https://doi.org/10.1161/CIRCULATIONAHA.123.067626 C-Reactive Protein and Cardiovascular Risk Among Women With No Standard Modifiable Risk Factors: Evaluating the 'Smurf-Less but Inflamed' https://doi.org/10.1093/eurheartj/ehaf658 Mortality in STEMI Patients Without Standard Modifiable Risk Factors: A Sex-Disaggregated Analysis of SWEDEHEART Registry Data https://doi.org/10.1016/S0140-6736(21)00272-5 Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women https://www.nejm.org/doi/10.1056/NEJMoa2405182 Statins for the 'SMuRFLess But Inflamed': Silent Vascular Inflammation and the Challenge of Translational Science https://doi.org/10.1016/j.jacbts.2025.101318 VERVE-101: A Promising CRISPR-Based Gene Editing Therapy That Reduces LDL-C and PCSK9 Levels in HeFH Patients https://academic.oup.com/ehjcvp/article/10/2/89/7492807 You may also like: Hear John Mandrola, MD, give a summary and his perspective on the top cardiology news each week, on This Week in Cardiology https://www.medscape.com/twic Questions or feedback, please contact news@medscape.net

This week, Dr. Kahn dives into new research linking plant-based diets to both a lower risk of type 2 diabetes and improved control in type 1 diabetes. (Fun fact: even eating one juicy mango a day can help with blood sugar control!) He also tackles the recent Consumer Reports headlines about lead in protein powders, explaining why the use of California's Prop 65 limits may have exaggerated the concern compared to what most health experts believe.  Finally, Dr. Kahn reviews new data on Lipoprotein(a) and heart health—including one fascinating study that connects risk levels to waist size.  This episode is brought to you by the Fresh Pressed Olive Oil Club. Get your discount at getfreshdrkahn.com .

This week, Dr. Joel Kahn explores three advanced methods for cleansing the blood. He begins with apheresis, a medical technique that removes LDL cholesterol and Lipoprotein(a), and discusses new developments in access to this life-saving therapy. Dr. Kahn also breaks down two emerging treatments gaining popularity—EBOO (Extracorporeal Blood Oxygenation and Ozonation) and TPE (Therapeutic Plasma Exchange)—and how they may play a role in improving cardiovascular health. In the second half, Dr. Kahn turns to the topic of cholesterol-lowering therapies like statins, emphasizing how long-term use and individualized risk assessment matter more than online debates suggest. He highlights tools such as the Mayo Clinic Statin Decision Aid, PREVENT calculator, and Astro-CHARM calculator to help patients and practitioners make informed decisions.  Thanks to the Fresh Pressed Olive Oil Club for sponsoring this episode. Visit getfreshdrkahn.com for a special offer.

This week, Dr. Kahn dives into the latest research on how healthy plant-based diets can benefit the body from head to almost toe — including lowering dementia risk, improving sexual health, reducing mortality, and supporting the planet. He also breaks down new studies showing the downsides of even one egg a day, the low testing rates of Lipoprotein(a), and why traditional heart risk factors still matter. Plus, hear how maintaining low cholesterol and heart-healthy habits starting at age 18 can dramatically improve long-term outcomes.  A packed episode filled with practical takeaways for your heart and overall health.

In this episode of The Neuro Experience, I sit down with Dr. Kellyann Niotis—one of the first fellowship-trained preventive neurologists—to reveal how you can protect your brain long before symptoms of Alzheimer's or dementia appear. With Alzheimer's cases expected to triple by 2050, Dr. Niotis explains the difference between dementia types, the real role of genes like ApoE4, and why lifestyle choices may be more powerful than genetics. If you want actionable tools to lower your risk, strengthen your memory, and understand the future of preventive neurology, this conversation delivers science-backed strategies you can start applying today. About Dr. Kellyann Niotis: Dr. Kellyann Niotis is the first fellowship-trained preventive neurologist focused on reducing risk for Alzheimer's, Parkinson's, and Lewy Body Dementia. She launched the nation's first Alzheimer's Prevention Clinic at Weill Cornell and now leads early-detection and brain health research at the Institute for Neurodegenerative Diseases Florida. Her work appears in leading medical journals and has been featured by CNN. *** Subscribe to The Neuro Experience for more conversations at the intersection of brain science and performance. I'm committed to bringing you evidence-based insights that you can apply to your own health journey. *** A huge thank you to my sponsors for supporting this episode:TimelineHead to⁠ http://timeline.com/neuro⁠ to get started. BeamVisit ⁠http://shopbeam.com/TNE⁠ and use code TNE at checkout. Jones Road BeautyHead to ⁠http://Jonesroadbeauty.com⁠ and use code NEURO at checkout. After you purchase, they will ask you where you heard about them. PLEASE support our show and tell them our show sent you. NOCDHead to ⁠http://learn.nocd.com/NEURO⁠ and book a free 15 minute call to get started. Eko HealthGo to ⁠http:/ekohealth.com/NEURO ⁠ for up to $50 off, plus a free chest piece cover.  *** I'm Louisa Nicola — clinical neuroscientist — Alzheimer's prevention specialist — founder of Neuro Athletics. My mission is to translate cutting-edge neuroscience into actionable strategies for cognitive longevity, peak performance, and brain disease prevention. If you're committed to optimizing your brain — reducing Alzheimer's risk — and staying mentally sharp for life, you're in the right place. Stay sharp. Stay informed. Join thousands who subscribe to the Neuro Athletics Newsletter → https://bit.ly/3ewI5P0 Instagram: https://www.instagram.com/louisanicola_/ Twitter : https://twitter.com/louisanicola_ *** Topics discussed: 00:00 – Introduction 01:25 – Preventative neurology 02:23 – Dementia vs. Alzheimer's & Other Types of Dementia 04:08 – What Is Alzheimer's? 05:26 – Clinical Diagnosis: Imaging & Symptoms 07:07 – How Amyloid Disrupts Neural Communication 09:48 – Genetics vs. Lifestyle: Public Misunderstanding 12:02 – Role of Family History & Genetic Risk 14:04 – The ApoE4 Gene Explained15:07 – ApoE Variants 17:08 – ApoE4 and Lipid Transport in the Brain 18:35 – Immune Response & Infection Susceptibility 20:05 – Hormones: Key Role in Brain Health 21:08 – Genotypes & Risk Multipliers 23:01 – ApoE4 Not Always Deterministic: Population Studies 24:15 – Other Genetic Factors Beyond ApoE 25:13 – Biomarkers: Current Use & Limitations 27:13 – Risks of Self-Testing Biomarkers 28:45 – Why Two-Thirds of Patients Are Women 29:46 – Estrogen, Menopause & Neuroprotection 32:07 – Testosterone & Dementia Risk 35:01 – LDL, ApoB & Brain Health Debate 37:01 – Statins & Dementia: Myths vs. Evidence 39:08 – Fear & Misconceptions Around Cholesterol 41:09 – Lipoprotein(a) & Vascular Dementia Risk 44:39 – Brain Vasculature & Hypertension 49:15 – New Alzheimer's Drugs & Risks 55:32 – Why Rates Keep Rising (Lifestyle & Stress) 58:11 – Early Signs 01:00:23 – Tau Protein, Tangles & Neuronal Damage 01:05:49 – Keto vs. Mediterranean 01:07:14 – Personalization & Preference for Mediterranean Diet Learn more about your ad choices. Visit megaphone.fm/adchoices

Dr. Hoffman continues his conversation with Jim LaValle, a clinical pharmacist and certified clinical nutritionist, detailing cholesterol's importance and its implications for cardiovascular health. 

September is Cholesterol Education Month. In this episode of Intelligent Medicine, Jim LaValle, a clinical pharmacist and certified clinical nutritionist, details cholesterol's importance and its implications for cardiovascular health. He delves into the nuances of cholesterol types, the historical shifts in perceptions of cholesterol, and how dietary and lifestyle factors influence cholesterol levels and cardiovascular risk. Jim provides expert insights into the roles of LDL and HDL cholesterol, the significance of cholesterol particle size, the impact of carbohydrates on cholesterol, and the benefits of aged garlic extract and other supplements. The conversation emphasizes the importance of comprehensive lipid testing, understanding individual risk factors, and integrating both lifestyle modifications and, when necessary, medications into cardiovascular preventive strategies. The episode concludes with a discussion on the role of health policies and the future of integrative health approaches.

Program notes:0:45 Intimate partner violence and CVD1:45 12% reported stalking2:46 Screening in primary care3:47 Fifty to 200% increased risk4:00 Number of psychiatric disorders and dementia risk5:00 Important to be aware when mental health disorders exist6:03 Anxiety and depression associated6:33 Lipoprotein(a) and widespread vascular disease7:31 High risk of extracoronary vascular disease8:32 Also associated with complications9:32 Unknown why some areas affected10:00 Second cancers after early invasive breast cancer11:00 Contralateral breast cancer greater in younger women12:00 Not excessive risk13:31 End

With Børge Nordestgaard and Anders Berg Wulff, Copenhagen University Hospital, Copenhagen - Denmark. Read the European Heart Journal - Cardiovascular Imaging paper Read the European Heart Journal - Cardiovascular Imaging editorial

We hear a lot about LDL cholesterol as a contributor to heart disease, however there's an inherited cholesterol containing particle that also plays a factor. On this episode, we sit down with Dr. Hugh Coyne to learn more about Lipoprotein(a), or Lp(a), and how its presence affects our risk for cardiovascular disease.Dr. Hugh Coyne is a general practitioner and the co-founder of Coyne Medical in Parsons Green, London. Coyne Medical, has two state of the art Private Doctors Surgeries. They aim to lead the market in providing high quality accessible healthcare, using the latest technology and evidence to offer patients individualised holistic care.Episode Links:Learn more about Coyne MedicalFollow Dr. Hugh on social media: Instagram | LinkedInAbout Propel:Propel is the purpose-built well-being platform designed to help you develop a culture of well-being and bring your vision to life. Propel helps you launch a truly engaging program with flexible technology that tailors the experience to your diverse teams.Create a unique well-being experience from within. See how Propel can help by scheduling a free strategy session at propelwellbeing.com.

Send us a textDr. Michael Koren joins Kevin Geddings to report live from Madrid on new developments being presented at the European Society of Cardiology meeting. This medical gathering, now the world's largest, is a showcase of developments in heart health and medicine. Dr. Koren notes excitement about progress in treating a genetic condition, lipoprotein(a), which raises cholesterol independently from diet and exercise. He notes that progress in this field is showing promise and that those with a family history of heart disease should have their lipoprotein(a) checked!Be a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on Apple PodcastsWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramX (Formerly Twitter)LinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Außerdem: Waldnutzung und Naturschutz - Passt das zusammen? (14:25) // Mehr spannende Themen wissenschaftlich eingeordnet findet Ihr hier: www.quarks.de // Habt Ihr Feedback, Anregungen oder Fragen, die wir wissenschaftlich einordnen sollen? Dann meldet Euch über Whatsapp oder Signal unter 0162 344 86 48 oder per Mail: quarksdaily@wdr.de. Von Yvonne Strüwing.

This week, Dr. Kahn breaks down the latest guidelines for preventing and treating high blood pressure. He reviews the top 10 lessons from an important new medical article and encourages every listener to own a home blood pressure cuff, use it regularly, and aim for readings under 120/80. Along the way, he also discusses new research on Lipoprotein(a) myths, EMF exposure, cystatin C kidney lab tests, the Fasting Mimicking Diet and its impact on kidney health (prolonlife.com/drkahn), and the role of vitamin C in overall wellness. Thanks to igennus.com for supporting the show, with a special discount available using the code DrKahn.

This week, Dr. Kahn discussed a new paper about the power of a Zero Score Calcium CT Scan in people without symptoms but concerns for soft plaque (non-calcified) in those with symptoms. Generally, patients with symptoms are better tested by Coronary CT Angiograms (CCTA), optimally with FFR and Cleerly Software analysis. He provides case studies from the clinic. Other topics include plant diets for Crohn's Disease prevention, the goal of 7,000 steps a day, Lipoprotein(a) and stroke, heart and brain risk control benefits, strategies to avoid weight gain, and erythritol and heart disease.  Thanks to Igennus.com and the discount code DrKahn.

Why do we screen for cancer but not the leading cause of death — heart disease? Today, we explore innovative strategies for early detection, prevention, and effective intervention in cardiovascular health.Join hosts Dr. Emmie Brown, ND, and Melissa Gentile, INHC, as they welcome Dr. Joel Kahn, a renowned cardiologist and advocate for plant-based nutrition and holistic approaches to heart health. Dr. Kahn delves into why heart disease has stubbornly remained the leading cause of death despite medical advancements, highlighting the need for a paradigm shift in prevention and early detection.Dr. Kahn critiques the current lack of attention paid to proactive cardiovascular screening, noting the puzzling discrepancy between routine cancer screenings and the absence of widespread use of tools like coronary artery calcium (CAC) CT scans for asymptomatic adults. He champions a personalized, comprehensive approach, moving beyond basic lipid panels and into genetic testing, advanced inflammatory markers, and detailed imaging.They also discuss dietary strategies, including debates on the role of protein and seed oils in heart risk, the importance of the endothelial glycocalyx, and recommendations for clinicians to assess and communicate vascular risk. Dr. Kahn challenges both traditional and trendy wellness beliefs, promoting evidence-based, personalized strategies in integrative cardiology.Key Takeaways from Today's Episode:

Part I: Caryn Hartglass, Long Term Vegan with High Cholesterol. Caryn gives a 1-year update on her journey to lower her cholesterol. As a long time vegan, this is challenging. She has been doing an SOS-free (salt, oil, sugar free) diet for one year. Part II: Ciara Sidell, Randall's Island Park Alliance Urban Farm Ciara Sidell is the Urban Farm Manager at Randall's Island Park Alliance in NYC. The Randall's Island Park Alliance (RIPA) is the proud steward of the beautiful Randall's Island Park, which is uniquely situation between three boroughs – Manhattan, the Bronx and Queens. For over 30 years, RIPA has worked in partnership with the City and the Parks Department to restore, maintain, sustain, develop, manage and program Randall's Island Park as a place for all New Yorkers to enjoy. Since its inception in 2006 the Urban Farm has grown in size and scope, featuring over 100 raised beds, two greenhouses, four rice paddies and a small fruit orchard. With education at the forefront of its design, the Urban Farm embodies the core belief that plants and children can grow side by side. With over 200 varieties of fruits and vegetables from around the world, the Urban Farm allows visitors to deepen their understanding of where food comes from. Strolling through the farm, you'll discover fruits and vegetables you've never seen in grocery stores and crops that are culturally relevant to our nearby communities. Through free hands-on classes and public events focused on sustainability, cooking, planting, and composting, farm visitors of all ages can explore locally-grown food in an urban environment. School groups can visit through our Edible Education Program, and we invite the public to explore during weekend open hours and many program offerings. The Urban Farm is located at the island's southern end, adjacent to the park's playground, a picnic area, playing fields, and a public restroom. The Randall's Island Park Alliance is proud to program and maintain the Urban Farm and greatly appreciates donations to help continue to make these events possible     Links mentioned in the podcast: Keene Garlic Lipid-lowering activity of artichoke extracts: A systematic review and meta-analysis Ron Weiss, MD, Ethos Primary Care and Ethos Farm Joel K. Kahn, MD, Lipoprotein(a), The Heart's Quiet Killer: A Diet & Lifestyle Guide

Lipoprotein (a) Elevation: What Does it do to CV Risk and What do You Need to Know About Treatment   Guest: Vlad Vasile, M.D., Ph.D. Host: Stephen L. Kopecky, M.D.   Lipoprotein (a) is a blood biomarker that poses independent risk of heart attacks and stroke when elevated. All patients should be screened for this biomarker. Currently, there are no efficient treatments for lipoprotein (a) elevations, but likely the scenery will change as we will have treatments available in the near future. For now, we recommend a healthy lifestyle, medications that lower cholesterol, aspirin and screening of all first-degree relatives of patients with elevated lipoprotein (a), including children.   Topics Discussed: What is lipoprotein (a)? How does lipoprotein (a) increase cardiovascular risk? How do we treat lipoprotein (a) elevation? Do you screen children of patients with elevated lipoprotein (a)?    Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App: The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode.   Podcast episode transcript found here.

Did you know that heart disease kills more midlife women than cancer, yet, most doctors aren't testing correctly? Heart disease is super close and personal to me. It's how I lost my dad when he was just 49…so it really hits home. Most of us think of men when we hear about heart attacks or heart disease, but did you know it's the #1 killer of women over 45? Yet most of us are completely focused on the wrong risk factors (yep, including most doctors). In this conversation, I sat down with cardiologist Dr. Joel Kahn, who's been practicing for 35 years and has a fascinating perspective that challenges much of what we've been told about heart health (in a great way). We get personal - I share my own labs live on air as Dr. Kahn walks through exactly what these numbers mean and what we should actually be testing for instead of the basic panel most doctors order. We dive deep into why women present with heart disease so differently than men, the tests every woman over 45 should demand from their doctor, and why your calcium score might be more important than your cholesterol number. You'll discover the real story behind the cholesterol controversy that's been raging since the 1970s, when statins are actually necessary, the shocking connection between how you cook your food and arterial aging, why antibacterial mouthwash might be damaging your blood vessels, and the advanced lab tests that give you real answers about your cardiovascular risk - not just outdated calculations from the 1960s. If you've ever been confused about conflicting advice on saturated fat, wondered if you really need that statin prescription, or want to know what actually protects your heart as you age, this episode provides the clarity you've been searching for. Dr. Kahn brings decades of research and clinical experience to help us separate the marketing from the medicine when it comes to women's heart health.   Catch the full episode on YOUTUBE HERE: https://bit.ly/MidlifeConversationsYouTube    Learn More About Dr. Joel Kahn:   Instagram ➜ https://www.instagram.com/drjkahn    Website ➜ https://drjoelkahn.com    Additional Episode Resources: Prevent Calculator: https://professional.heart.org/en/guidelines-and-statements/prevent-calculator  Book: "Lipoprotein(a): The Heart's Quiet Killer"  Study Dr. Kahn was co-author on establishing lifelong exposure to either slight reductions in LDL-C or slight elevations determines heart disease risk long term. Widely quoted paper: https://pubmed.ncbi.nlm.nih.gov/23083789/ The most widely quoted paper establishing LDL-C as a cause, not just risk factor, of atherosclerosis: https://pubmed.ncbi.nlm.nih.gov/28444290/ A recent paper on Lipoprotein(a) cholesterol inherited by 20-25% of people, not currently FDA approved Rx as statins do not work for it, but new Rx med in the pipeline. Similar risk to men and women: https://pubmed.ncbi.nlm.nih.gov/40240882/ Try a bottle of the world's most delicious artisanal, high-quality olive oils direct from gold-medal-winning small farms for just $1 and taste the difference https://GetFreshNatalieJill.com  Thank you to our show sponsors! LIVON: Save $56 (get a free B Complex) with purchase of the Midlife Bundle at http://livonlabs.com/nataliejill  Free Gifts for being a listener of Midlife Conversations! Mastering the Midlife Midsection Guide: https://theflatbellyguide.com/ Age Optimizing and Supplement Guide: https://ageoptimizer.com   Connect with me on social media! Instagram: www.Instagram.com/Nataliejllfit Facebook: www.Facebook.com/Nataliejillfit   For advertising inquiries: https://www.category3.ca/  Disclaimer: Information provided in the Midlife Conversations podcast is for informational purposes only. This information is NOT intended as a substitute for the advice provided by your physician or other healthcare professional. Do not use the information provided in this podcast for diagnosing or treating a health problem or disease, or prescribing medication or other treatment. Always speak with your physician or other healthcare professional before making any changes to your current regimen.  Information provided in this podcast and the use of any products or services related to this podcast does not create a client-patient relationship between you and the host of Midlife Conversations or you and any doctor or provider interviewed and featured on this show. Information and statements may have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent ANY disease. Advertising Disclosure: Some episodes of Midlife Conversations may be sponsored by products or services discussed during the show. The host may receive compensation for such advertisements or if you purchase products through affiliate links. Opinions expressed about products or services are those of the host and/or guests and do not necessarily reflect the views of any sponsor. Sponsorship does not imply endorsement of any product or service by healthcare professionals featured on this podcast.

Elevated levels of lipoprotein(a) are associated with higher rates of cardiovascular events. Author Samia Mora, MD, MHS, of Brigham and Women's Hospital and Harvard Medical School discusses measurement and interpretation of lipoprotein (a) levels with JAMA Deputy Editor Mary McGrae McDermott, MD. Related Content: Lipoprotein(a)

This week, Dr. Kahn reviews new research linking chicken consumption to increased mortality, particularly from gastrointestinal cancers. He discusses additional studies that suggest chicken may not be the health food many believe it is and highlights healthier alternatives, including plant-based options like tofu, tempeh, beans, and lentils. Dr. Kahn also covers new research on Lipoprotein(a), heart disease in younger populations, and the impact of air pollution on cardiovascular health. Special thanks to endur.com — use the discount code KahnMD10 for savings on your purchases.

Dr Steve and Dr Scott Discuss: despondent over missing Hackamania (stay tuned, there may be an answer) Stupid Cletus Puppet Cancer staging Lipoprotein(a) Dr Perkins isn't a doctor, apparently? HPV vaccine sweating after exertion male morning sickness fluid family stuff youtube.com/@weirdmedicine Please visit: simplyherbals.net/cbd-sinus-rinse (the best he's ever made. Seriously.) instagram.com/weirdmedicine x.com/weirdmedicine stuff.doctorsteve.com (it's back!) youtube.com/@weirdmedicine (click JOIN and ACCEPT GIFTED MEMBERSHIPS. Join the "Fluid Family" for live recordings!) youtube.com/@normalworld (Check out Dave and crew, and occasionally see your old pal!) CHECK OUT THE ROADIE COACH stringed instrument trainer! roadie.doctorsteve.com (the greatest gift for a guitarist or bassist! The robotic tuner!) see it here: stuff.doctorsteve.com/#roadie Also don't forget: Cameo.com/weirdmedicine (Book your old pal right now because he's cheap! "FLUID!") Most importantly! CHECK US OUT ON PATREON!  ALL NEW CONTENT! Robert Kelly, Mark Normand, Jim Norton, Gregg Hughes, Anthony Cumia, Joe DeRosa, Pete Davidson, Geno Bisconte, Cassie Black ("Safe Slut"). Stuff you will never hear on the main show ;-) Learn more about your ad choices. Visit podcastchoices.com/adchoices

This week on Heart Doc VIP, Dr. Joel Kahn breaks down the game-changing TRANSFORM Study—an important piece of research that could shift how we approach heart attack prevention. He also covers a wide range of must-know topics, including Lipoprotein(a), coronary calcium CT scoring, heart-smart nutrition (for both you and the planet), smoothie tips, Vitamin C, and new findings on the potential risks of gadolinium-based contrast in MRI scans. Special thanks to our sponsor: Endur.com. Try Dihydroberberine-SR with code KahnMD10 for a discount.

Let's break down key insights from a recent two-hour and 20-minute conversation between Dr. Peter Attia and renowned lipidologist Tom Dayspring. Support your Intermittent Fasting lifestyle with the Berberine Fasting Accelerator  by MYOXCIENCE: https://bit.ly/berberine-fasting-accelerator Use code podcast to save 12% Get the Blood Work Cheat Sheet: https://courses.highintensityhealth.com/blood-work-cheat-sheet Show Notes: https://bit.ly/4hrDc72 Time Stamps:  0:00 Intro 0:52 Cholesterol's Role in Atherosclerosis  1:51 Triglycerides & Insulin Resistance: The Overlooked Risk Markers  3:28 Lipoprotein Exchange & Insulin Resistance  7:18 Triglycerides to HDL Ratio as a Risk Indicator  8:36 Metabolically Healthy Phenotype & LDL: 9:20 Sauna Therapy for Cardiovascular Health: 11:00 Cholesterol, Endothelial Health & Plaque Formation: 14:53 Case Study: A 24-Year-Old Athlete with High LDL 21:00 Lipoprotein(a) (LP(a)) and Its Role in Cardiovascular Risk:

The Reversing Heart Disease Summit 3.0 is now live! Register today to access expert insights on heart health: Reversing Heart Disease Summit. This week, Dr. Kahn explores new research on Lipoprotein(a) [Lp(a)], a topic he has long studied. He discusses recent findings on Lp(a)'s potential protective role in the liver and its link to calcific aortic stenosis, a condition affecting the aortic valve. Additional topics include new insights into long COVID and the potential role of nicotine, the benefits of the Prolon fasting-mimicking diet for gum health, and how hearing loss may contribute to cognitive decline—along with how diet might help. Dr. Kahn also breaks down the relationship between cardiac health and brain function (Life's Essential 8) and reviews another study confirming that statins may help protect against dementia. Plus, he shares a fascinating case study on the Kempner diet and its effects.  Special thanks to our sponsor, Endurance Products. Use code KahnMD10 for a discount.  You can also order Prolon at prolonlife.com/drkahn.